MENU
+Compare
VCEL
Stock ticker: NASDAQ
AS OF
Nov 13 closing price
Price
$39.84
Change
-$0.60 (-1.48%)
Capitalization
2.01B

VCEL Vericel Corp Forecast, Technical & Fundamental Analysis

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets... Show more

VCEL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for VCEL with price predictions
Nov 12, 2025

Momentum Indicator for VCEL turns positive, indicating new upward trend

VCEL saw its Momentum Indicator move above the 0 level on November 05, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned positive. In of the 94 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for VCEL just turned positive on November 03, 2025. Looking at past instances where VCEL's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

VCEL moved above its 50-day moving average on October 16, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for VCEL crossed bullishly above the 50-day moving average on October 17, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VCEL advanced for three days, in of 287 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 249 cases where VCEL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 72 cases where VCEL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VCEL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VCEL broke above its upper Bollinger Band on November 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VCEL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VCEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.262) is normal, around the industry mean (24.439). P/E Ratio (153.231) is within average values for comparable stocks, (63.753). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.001). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (8.143) is also within normal values, averaging (322.723).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
VCEL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

VCEL is expected to report earnings to rise 317.40% to 41 cents per share on February 26

Vericel Corp VCEL Stock Earnings Reports
Q4'25
Est.
$0.42
Q3'25
Beat
by $0.11
Q2'25
Beat
by $0.02
Q1'25
Missed
by $0.10
Q4'24
Beat
by $0.07
The last earnings report on November 06 showed earnings per share of 10 cents, beating the estimate of 0 cents. With 435.35K shares outstanding, the current market capitalization sits at 2.01B.
A.I. Advisor
published General Information

General Information

a developer of patient-specific expanded cellular therapies for use in the treatment of patients with diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
64 Sidney Street
Phone
+1 617 588-5555
Employees
314
Web
https://www.vcel.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEORX33.250.19
+0.57%
First Eagle Overseas R6
PGJCX18.340.05
+0.27%
PGIM Jennison Global Infrastructure C
FSRPX19.96N/A
N/A
Fidelity Select Retailing
FANIX51.50N/A
N/A
Fidelity Advisor Energy I
IJSIX14.61-0.01
-0.07%
VY® JPMorgan Small Cap Core Equity I

VCEL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VCEL has been loosely correlated with VCYT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VCEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCEL
1D Price
Change %
VCEL100%
-1.49%
VCYT - VCEL
52%
Loosely correlated
-0.84%
TECH - VCEL
42%
Loosely correlated
+3.75%
BEAM - VCEL
39%
Loosely correlated
-2.71%
FTRE - VCEL
39%
Loosely correlated
-3.82%
AXON - VCEL
38%
Loosely correlated
-0.47%
More